Your browser doesn't support javascript.
loading
Novel therapies for acromegaly.
Maia, Bernardo; Kasuki, Leandro; Gadelha, Mônica R.
Affiliation
  • Maia B; Neuroendocrinology Research Center/Endocrinology Division - Medical School and Hospital Universitário Clementino Fraga Filho - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Kasuki L; Neuroendocrinology Research Center/Endocrinology Division - Medical School and Hospital Universitário Clementino Fraga Filho - Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
  • Gadelha MR; Neuroendocrinology Division - Instituto Estadual do Cérebro Paulo Niemeyer, Rio de Janeiro, Brazil.
Endocr Connect ; 9(12): R274-R285, 2020 Dec.
Article in En | MEDLINE | ID: mdl-33434151
Acromegaly is a systemic disease associated with increased morbidity and mortality. Most of these comorbidities can be prevented or delayed with adequate disease treatment. Although three modalities of treatment (surgery, medical treatment, and radiotherapy) are available and new drugs were approved in the last decades, there are still some patients that maintain disease activity despite treatment. Therefore, there is a need for novel therapies for acromegaly and for that purpose new formulations of currently used drugs and also new drugs are currently under study. In this review, we summarize the novel therapies for acromegaly.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Endocr Connect Year: 2020 Document type: Article Affiliation country: Brazil Country of publication: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Endocr Connect Year: 2020 Document type: Article Affiliation country: Brazil Country of publication: United kingdom